Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giangiacomo Torri

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Molecules (Basel, Switzerland)|February 1, 2018
Remembering Professor Benito Casu (1927-2016)Giangiacomo Torri, Giuseppe Cassinelli
Molecules (Basel, Switzerland)|February 1, 2018
Looking Forward to the Future of Heparin: New Sources, Developments and ApplicationsGiangiacomo Torri, Giuseppe Cassinelli
International Journal of Cardiology|June 7, 2016
Heparin centenary - an ever-young life-saving drugGiangiacomo Torri, Annamaria Naggi
Carbohydrate Research|August 5, 2014
Re-visiting the structure of heparinBenito Casu, Annamaria Naggi, Giangiacomo Torri
Advances in Experimental Medicine and Biology|April 11, 2020
Non-Anticoagulant Heparins as Heparanase InhibitorsGiuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi
Matrix Biology : Journal of the International Society for Matrix Biology|April 27, 2010
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancerBenito Casu, Annamaria Naggi, Giangiacomo Torri
Seminars in Thrombosis and Hemostasis|September 24, 2002
Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycansBenito Casu, Annamaria Naggi, Giangiacomo Torri
Current Pharmaceutical Design|April 14, 2004
Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfateBenito Casu, Marco Guerrini, Giangiacomo Torri
Current Pharmaceutical Design|July 14, 2007
Interaction of heparins with fibroblast growth factors: conformational aspectsMarco Guerrini, Milos Hricovíni, Giangiacomo Torri
Seminars in Thrombosis and Hemostasis|January 14, 2004
Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patternsClaudia Sissi, Annamaria Naggi, Giangiacomo Torri, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Molecules (Basel, Switzerland)|February 1, 2018
Remembering Professor Benito Casu (1927-2016)Giangiacomo Torri, Giuseppe Cassinelli
Molecules (Basel, Switzerland)|February 1, 2018
Looking Forward to the Future of Heparin: New Sources, Developments and ApplicationsGiangiacomo Torri, Giuseppe Cassinelli
International Journal of Cardiology|June 7, 2016
Heparin centenary - an ever-young life-saving drugGiangiacomo Torri, Annamaria Naggi
Carbohydrate Research|August 5, 2014
Re-visiting the structure of heparinBenito Casu, Annamaria Naggi, Giangiacomo Torri
Advances in Experimental Medicine and Biology|April 11, 2020
Non-Anticoagulant Heparins as Heparanase InhibitorsGiuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi
Matrix Biology : Journal of the International Society for Matrix Biology|April 27, 2010
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancerBenito Casu, Annamaria Naggi, Giangiacomo Torri
Seminars in Thrombosis and Hemostasis|September 24, 2002
Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycansBenito Casu, Annamaria Naggi, Giangiacomo Torri
Current Pharmaceutical Design|April 14, 2004
Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfateBenito Casu, Marco Guerrini, Giangiacomo Torri
Current Pharmaceutical Design|July 14, 2007
Interaction of heparins with fibroblast growth factors: conformational aspectsMarco Guerrini, Milos Hricovíni, Giangiacomo Torri
Seminars in Thrombosis and Hemostasis|January 14, 2004
Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patternsClaudia Sissi, Annamaria Naggi, Giangiacomo Torri, et al.
Pageof 10